在免疫检查点抑制剂治疗时代的毒性
Synat Keam1, Naimah Turner1, Fernanda G Kugeratski1
1Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Frontiers in immunology
|September 9, 2024
概括
免疫检查点抑制剂 (ICI) 可以导致影响各种器官的免疫相关不良事件 (irAEs). 本综述涵盖了用于理解和管理这些毒性的临床前模型,这对于有效的癌症治疗至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 毒理学 毒理学 毒理学
背景情况:
- 针对PD-1和CTLA-4的免疫检查点抑制剂 (ICI) 是有效的癌症疗法.
- ICI可以引起影响多个器官系统的免疫相关不良事件 (irAEs).
- 目前尚不完全了解iRAE背后的机制,需要更好的临床前模型.
研究的目的:
- 审查目前免疫检查点抑制剂 (ICI) 诱导的免疫相关不良事件 (irAEs) 的临床前模型.
- 讨论各种ICI诱导毒性的免疫影响和管理策略.
- 突出需要改进的模型来理解irAE的发展.
主要方法:
- 对ICI诱导毒性的临床前模型的文献综述.
- 分析与irAEs相关的免疫机制.
- 对IRE的临床管理策略的摘要.
主要成果:
- 临床前模型对于研究ICI诱导的皮肤,胃肠道,神经,内分泌,肺,关节和心脏毒性至关重要.
- 了解这些模型中的免疫反应有助于预测和管理irAEs.
- 目前的模型提供了对irAEs病原体的洞察.
结论:
- 有效的临床前模型对于阐明ICI诱导的IRE机制至关重要.
- 更好地了解irAE将有助于制定有针对性的管理策略.
- 需要使用强大的临床前模型进行进一步的研究,以优化ICI治疗,同时最大限度地降低毒性.
相关概念视频
Tumor Immunotherapy
491
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
491
Cytotoxic T Cells-mediated Immune Response
859
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
859
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


